Zanganeh Mahkam bought SMMT
June 12, 2026 · Form 4 insider transaction
Zanganeh Mahkam bought 3,810,000 shares of Summit Therapeutics Inc. at $13.12 per share, a transaction worth $49.99M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,810,000
Price
$13.12
Total value
$49.99M
InsiderZanganeh Mahkam
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 12, 2026
Filing dateJune 12, 2026
Shares owned after573,883,879
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.